BHANDAL CARE LIMITED
Company number 12591830 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BHANDAL CARE LIMITED - Analysis Report
Company Number: 12591830
Analysis Date: 2025-07-20 15:00 UTC
Financial Health Assessment: BHANDAL CARE LIMITED
1. Financial Health Score: C
Explanation:
The company shows modest improvement in its financial position over the last few years but still carries signs of financial strain. The net asset base is positive but very slim (£405 in 2024) indicating fragile equity. There is a consistent pattern of net current liabilities, which suggests liquidity challenges despite growth in current assets. Overall, the financial health is stable but vulnerable, warranting cautious optimism.
2. Key Vital Signs (Critical Metrics & Interpretation):
| Metric | 2024 Value | Interpretation (Medical Analogy) |
|---|---|---|
| Net Assets (Equity) | £405 | "Body weight" of the company—just above zero, indicating weak but positive net worth. |
| Net Current Assets (Working Capital) | -£961 | "Pulse irregularity": Negative working capital shows current liabilities slightly exceed current assets, implying tight liquidity. |
| Fixed Assets | £1,366 | "Skeletal structure": Small but growing fixed asset base, indicating some investment in long-term resources. |
| Current Assets | £41,673 | "Blood flow": Healthy cash and receivables have increased significantly, indicating better short-term asset availability. |
| Current Liabilities | £42,634 | "Immediate debts": High short-term obligations putting pressure on cash flow. |
| Share Capital | £1.00 | Minimal initial capital, typical of micro-entities, relying heavily on retained earnings and loans. |
| Director Loan Advances | £23,205 | "Internal support": Director has provided unsecured loans, showing personal financial backing. |
3. Diagnosis: What the Financial Data Reveals
Liquidity Stress Signs: The company’s negative net current assets (working capital) is a symptom of liquidity strain. This "shortness of breath" means it may struggle to meet short-term obligations without additional cash inflows or financing. While the gap has narrowed (from -£35,763 in 2021 to -£961 in 2024), it still presents a risk.
Fragile Equity Position: The net assets are positive but very thin. This "low blood pressure" condition implies that while the company is not insolvent, it has little buffer to absorb financial shocks or losses.
Improvement Trend: There is a clear improvement over the 5-year history from significant negative equity and working capital to positive net assets and reduced current liabilities. This suggests the company is recovering well from earlier financial distress.
Reliance on Director Financing: The director’s loans represent an "intravenous drip" helping the business maintain liquidity and operations, highlighting dependency on internal support rather than external funding.
Operational Scale: With an average of 19 employees and classification as a micro-entity, the company is in a growth phase, building infrastructure and increasing working capital.
Industry Context: Operating in residential care for elderly and disabled persons, the company’s financial health is critical to sustaining regulatory compliance and service quality.
4. Recommendations: Specific Actions to Improve Financial Wellness
Enhance Liquidity Management: Implement tighter control on receivables and payables to improve working capital. Aim to convert current liabilities into longer-term debts where possible to ease short-term cash flow pressure.
Increase Equity Base: Consider injecting additional capital or retaining profits to strengthen the net asset base. This will provide a healthier "immune system" to withstand unforeseen expenses.
Formalize Director Loans: Establish clear repayment terms or convert some director loans into equity to reduce debt burden and improve financial ratios.
Monitor Cash Flow Regularly: Use rolling cash flow forecasts as a "vital signs monitor" to anticipate and address liquidity issues proactively.
Cost Control and Efficiency: Review operational expenses to ensure they align with revenue growth, helping maintain a "healthy metabolism."
Explore External Funding Options: Investigate possible grants, subsidies, or ethical investment options available in the healthcare sector to diversify funding sources.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.